Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures

Abstract. Patients with 22q11.2 deletion syndrome have characteristic facial appearance, palate abnormalities, hypoparathyroidism, thymic hypoplasia, and congenital heart disease. The 22q11.2 region includes TBX1 and 30 other genes. Analysis of Tbx1 transgenic mice showed that TBX1 was associated with the 22q11.2 deletion syndrome. In humans, TBX1 mutations have been reported in 22q11.2 deletion-negative patients with velocardiofacial syndrome or DiGeorge syndrome. Genotype-phenotype correlations are not fully understood in these patients. We report the case of an infant with a novel heterozygous TBX1 mutation who experienced hypocalcemic seizures. This patient had no palate abnormalities, cardiac anomalies, or the typical facial appearance observed in 22q11.2 deletion syndrome. The presence of thymic hypoplasia prompted us to perform G-banding, fluorescent in situ hybridization, and subsequent TBX1 analysis. We emphasize the importance of diagnosing thymic hypoplasia in hypocalcemic infants without 22q11.2 deletion for detecting TBX1 mutations.

[1]  S. Eliez,et al.  22q11.2 deletion syndrome , 2019, Nature Reviews Disease Primers.

[2]  Ruo-Gu Li,et al.  A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease , 2015, Pediatric Cardiology.

[3]  Jonathan H. Chung,et al.  Mouse and human CRKL is dosage sensitive for cardiac outflow tract formation. , 2015, American journal of human genetics.

[4]  N. de Leeuw,et al.  Central 22q11.2 deletions , 2014, American journal of medical genetics. Part A.

[5]  K. Nakayama,et al.  TBX1 Mutation Identified by Exome Sequencing in a Japanese Family with 22q11.2 Deletion Syndrome-Like Craniofacial Features and Hypocalcemia , 2014, PloS one.

[6]  Y. Moreau,et al.  Congenital heart defects in a novel recurrent 22q11.2 deletion harboring the genes CRKL and MAPK1 , 2012, American journal of medical genetics. Part A.

[7]  H. Sticht,et al.  Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. , 2007, American journal of human genetics.

[8]  Joe C. Adams,et al.  Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. , 2004, Human molecular genetics.

[9]  S. Minoshima,et al.  Role of TBX1 in human del22q11.2 syndrome , 2003, The Lancet.

[10]  E. Zackai,et al.  Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects , 2001, Journal of medical genetics.

[11]  V. Papaioannou,et al.  DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1 , 2001, Nature Genetics.

[12]  P. Scambler,et al.  Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice , 2001, Nature.

[13]  Birgit Funke,et al.  TBX1 Is Responsible for Cardiovascular Defects in Velo-Cardio-Facial/DiGeorge Syndrome , 2001, Cell.

[14]  E. Zackai,et al.  Skeletal anomalies and deformities in patients with deletions of 22q11. , 1997, American journal of medical genetics.